These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33145286)

  • 21. Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
    Bai T; Mai R; Ye J; Chen J; Qi L; Tang J; Wei M; Zhang L; Chen Z; Tang Z; Li L; Wu F
    Transl Cancer Res; 2020 Mar; 9(3):1384-1394. PubMed ID: 35117486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.
    Lei Y; Wang X; Tian Y; Xu R; Pei J; Fu Y; Sun H; Wang Y; Zheng P; Xia F; Wang J
    Front Med (Lausanne); 2023; 10():1209403. PubMed ID: 37841010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
    Front Oncol; 2020; 10():1758. PubMed ID: 33224869
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of phenotypic transformation of circulating tumor cells and early recurrence in patients with hepatocellular carcinoma following liver transplantation.
    Xie YL; Yang Z; Feng X; Yang Q; Ye LS; Li XB; Tang H; Zhang YC; Liu W; Tong Zhang ; Fu BS; Yi SH; Yang Y; Chen GH
    Asian J Surg; 2022 Jan; 45(1):435-440. PubMed ID: 34426060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study.
    Zhang Q; Xia F; Mo A; He W; Chen J; Zhang W; Chen W
    Front Oncol; 2022; 12():839597. PubMed ID: 35664772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
    BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
    Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
    Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report.
    Deng Y; Sun L; Liang H; Cui B; Cui C; Zhao D; Wan A; Wan G
    Front Oncol; 2021; 11():760765. PubMed ID: 34745999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
    Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
    Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma.
    Zhou KQ; Sun YF; Cheng JW; Du M; Ji Y; Wang PX; Hu B; Guo W; Gao Y; Yin Y; Huang JF; Zhou J; Fan J; Yang XR
    EBioMedicine; 2020 Dec; 62():103107. PubMed ID: 33181461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study.
    Wang PX; Sun YF; Zhou KQ; Cheng JW; Hu B; Guo W; Yin Y; Huang JF; Zhou J; Fan J; Cheung TT; Qu XD; Yang XR
    Clin Transl Med; 2020 Jul; 10(3):e137. PubMed ID: 32702202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma.
    Ye X; Li G; Han C; Han Q; Shang L; Su H; Han B; Gong Y; Lu G; Peng T
    Cancer Manag Res; 2018; 10():5639-5647. PubMed ID: 30532586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?
    Sawabata N; Nakamura T; Kawaguchi T; Watanabe T; Ouji NS; Ito T; Taniguchi S
    J Thorac Dis; 2020 Sep; 12(9):4623-4632. PubMed ID: 33145035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter
    Jin L; Fan WH; Luan Y; Wu M; Zhao W
    PeerJ; 2021; 9():e11366. PubMed ID: 33987029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.